Abstract

Dec 2, 2014, will mark a historic launch 1 EDCTPLaunch of the second EDCTP programme against poverty related diseases in Africa. European and Developing Countries Clinical Trials Partnership, The Hague2014http://www.edctp.org/media-centre/news/announcement/launch-of-the-second-edctp-programme-against-poverty-related-diseases-in-africa/ Google Scholar in Cape Town, South Africa—under the auspices of the South African Department of Science and Technology—of the second European and Developing Countries Clinical Trials Partnership Programme (EDCTP2), which was recently approved by the European Union (EU). 2 The European Parliament and the Council of the European UnionDecision No 556/2014/EU of the European Parliament and of Council of May 2014 on the participation of the Union in a second European and Developing Countries Clinical Trials Partnership Programme (EDCTP2) jointly undertaken by several Member States. Official Journal of the European Union. 2014; L169 (accessed Oct 16, 2014).: 38-53http://www.edctp.org/fileadmin/documents/Towards_EDCTP_II/EDCTP2-Decision556_2014_EU_2014-05-15.pdf Google Scholar , 3 The European Parliament and the Council of the European UnionDecision no 1209/2003/ec of the European parliament and of the council of 16 June 2003. Official Journal of the European Union. 2014; L169 (accessed Oct 16, 2014).: 1-5ftp://ftp.cordis.europa.eu/pub/fp7/art169/docs/edctp.pdf Google Scholar At the launch, the role and strategic vision of the EDCTP2 programme will be shared, synergies with other worldwide initiatives for Africa explored, and successes of the previous EDCTP programme celebrated. Funding of around €1·4 billion for the next 10 years (2014–23) is available for the EDCTP2 programme.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.